LH
Labcorp Holdings Inc. · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -0.9% · nuevas posiciones netas -5.3% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 88.13K | $17.42M | n/a | n/a |
| Q2 2026 | 156 | +5 | 55.88M | $15.63B | +9 | −5 |
| Q1 2026 | 155 | +1 | 55.32M | $14.74B | +4 | −4 |
| Q4 2025 | 153 | -1 | 61.82M | $15.50B | +1 | −1 |
| Q3 2025 | 19 | 0 | 33.10M | $9.50B | n/a | −1 |
| Q2 2025 | 17 | -1 | 30.31M | $7.95B | +1 | −2 |
| Q1 2025 | 15 | +2 | 7.94M | $1.85B | +2 | n/a |
| Q4 2024 | 13 | 0 | 9.58M | $2.20B | +2 | −2 |
| Q3 2024 | 12 | +1 | 4.32M | $962.67M | +2 | −1 |
| Q2 2024 | 11 | n/a | 5.93M | $1.21B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 9.81M | -0.7% | $2.82B | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (pasivo) | 8.13M | -10.3% | $2.33B | 0.0% | ▼ Trim | 2 | SEC ↗ ×20 |
| 3 | State Street Global Advisors ✦ (pasivo) | 3.83M | -0.8% | $1.10B | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | JPMorgan Chase ✦ | 2.15M | n/a | $616.63M | 0.0% | n/c | 1 | SEC ↗ ×30 |
| 5 | Geode Capital Management ✦ (pasivo) | 2.12M | +0.5% | $606.94M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Wellington Management ✦ | 2.11M | +15.9% | $604.49M | 0.1% | ▲ Add | 6 | SEC ↗ ×8 |
| 7 | Morgan Stanley ✦ | 1.51M | n/a | $432.71M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 8 | Fidelity (FMR) ✦ | 1.45M | -13.5% | $415.73M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 9 | Marshall Wace ✦ | 623.55K | +79.1% | $179.00M | 0.2% | ▲ Add | 3 | SEC ↗ ×3 |
| 10 | Citadel Advisors ✦ | 516.55K | +268.3% | $148.28M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Goldman Sachs Group ✦ | 422.15K | n/a | $121.18M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 12 | AQR Capital Management ✦ | 163.33K | +4.2% | $46.42M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 13 | T. Rowe Price ✦ | 120.19K | -0.3% | $34.50M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | Gotham Asset Management ✦ | 95.03K | +39.2% | $27.28M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 23.70K | 0.0% | $6.80M | 0.0% | Held | 4 | SEC ↗ |
| 16 | Millennium Management ✦ | 10.70K | -35.5% | $3.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 10.39K | +275.1% | $2.98M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 5.31K | -76.3% | $1.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Fisher Asset Management ✦ | 1.73K | +4.2% | $496,671 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Norges Bank | $263.07M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1,014 tenedores, 76.41M acciones, $19.36B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 3.00K acc. · $954,060
Officer, Director · 4.67K acc. · $1.50M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología